A detailed history of Mirova transactions in Eli Lilly & CO stock. As of the latest transaction made, Mirova holds 23,213 shares of LLY stock, worth $18.5 Million. This represents 3.59% of its overall portfolio holdings.

Number of Shares
23,213
Previous 25,662 9.54%
Holding current value
$18.5 Million
Previous $23.2 Million 11.48%
% of portfolio
3.59%
Previous 4.28%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $1.89 Million - $2.35 Million
-2,449 Reduced 9.54%
23,213 $20.6 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $1.28 Million - $1.61 Million
-1,770 Reduced 6.45%
25,662 $23.2 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $3.39 Million - $4.53 Million
5,720 Added 26.34%
27,432 $21.3 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $1.29 Million - $1.52 Million
-2,456 Reduced 10.16%
21,712 $12.7 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $672,915 - $927,716
-1,548 Reduced 6.02%
24,168 $13 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $1.12 Million - $1.49 Million
-3,182 Reduced 11.01%
25,716 $12.1 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $32,305 - $37,941
104 Added 0.36%
28,898 $9.92 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $322,836 - $376,168
1,004 Added 3.61%
28,794 $10.5 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $4.92 Million - $5.61 Million
-16,596 Reduced 37.39%
27,790 $8.99 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $720,238 - $845,665
2,584 Added 6.18%
44,386 $14.4 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $3.16 Million - $3.93 Million
13,470 Added 47.54%
41,802 $12 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $619,686 - $769,034
-2,756 Reduced 8.87%
28,332 $7.83 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $552,227 - $679,593
-2,492 Reduced 7.42%
31,088 $7.18 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $180,369 - $233,306
999 Added 3.07%
33,580 $7.71 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $545,542 - $706,230
3,320 Added 11.35%
32,581 $6.09 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $919,612 - $1.22 Million
7,049 Added 31.74%
29,261 $4.94 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $84,515 - $97,757
578 Added 2.67%
22,212 $3.29 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $847,577 - $1.02 Million
6,213 Added 40.29%
21,634 $3.55 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $904,303 - $1.12 Million
7,596 Added 97.07%
15,421 $2.14 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $571,059 - $707,308
5,341 Added 215.02%
7,825 $1.03 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $13,455 - $14,636
126 Added 5.34%
2,484 $278,000
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $163,180 - $192,075
1,466 Added 164.35%
2,358 $306,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $94,462 - $105,826
892 New
892 $103,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mirova Portfolio

Follow Mirova and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.